Base de dados : MEDLINE
Pesquisa : D02.033.100.291.617.300 [Categoria DeCS]
Referências encontradas : 163 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 17 ir para página                         

  1 / 163 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
PubMed Central Texto completo
Texto completo
[PMID]:26656358
[Au] Autor:Ohkura Y; Ueno M; Iizuka T; Haruta S; Tanaka T; Udagawa H
[Ad] Endereço:From the Department of Gastroenterological Surgery (YO, MU, SH, TT, HU), and Department of Gastroenterology (TI), Toranomon Hospital, Tokyo, Japan.
[Ti] Título:New Combined Medical Treatment With Etilefrine and Octreotide for Chylothorax After Esophagectomy: A Case Report and Review of the Literature.
[So] Source:Medicine (Baltimore);94(49):e2214, 2015 Dec.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Postoperative chylothorax is a rare but well-known complication of general thoracic surgery. Medical treatment of chylothorax was reported in the past, but there is still considerable controversy on the appropriate management strategies.Two patients with esophageal cancer underwent esophagectomy, 2-field lymph node dissection, and resection of thoracic duct together with ileocolic reconstruction via the retrosternal route at our hospital. Chylothorax developed on the 32nd postoperative day (POD) in 1 patient and the 12th POD in the other, manifesting as a change in the character of thoracic drainage to turbid white. Both were immediately started on octreotide (300 µg/ day) and etilefrine (120 mg/day). When the amount of pleural effusion decreased to <50 mL/day, we performed pleurodesis with Picibanil (OK432). Thereafter, the patients gradually made satisfactory progress and resumed oral food intake, and the thoracotomy tubes were eventually removed. They have remained recurrence-free at the time of writing.In this report, we demonstrated the clinical efficacy of etilefrine for the management of postesophagectomy chylothorax. New medical treatment options for this condition are now broad and the usefulness of combined therapy consisting of a sclerosing agent, etilefrine, and octreotide is underscored, regardless of the status of the thoracic duct.
[Mh] Termos MeSH primário: Quilotórax/tratamento farmacológico
Quilotórax/etiologia
Neoplasias Esofágicas/cirurgia
Esofagectomia/efeitos adversos
Etilefrina/uso terapêutico
Octreotida/uso terapêutico
[Mh] Termos MeSH secundário: Adulto
Antineoplásicos/uso terapêutico
Quimioterapia Combinada
Etilefrina/administração & dosagem
Seres Humanos
Masculino
Meia-Idade
Octreotida/administração & dosagem
Picibanil/uso terapêutico
Derrame Pleural/terapia
Pleurodese/métodos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antineoplastic Agents); 39325-01-4 (Picibanil); RWM8CCW8GP (Octreotide); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1604
[Cu] Atualização por classe:170224
[Lr] Data última revisão:
170224
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:151215
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000002214


  2 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:26240886
[Ti] Título:Drugs for hypotension: disproportionate harms with etilefrine and heptaminol. .
[So] Source:Prescrire Int;24(162):184, 2015 Jul.
[Is] ISSN:1167-7422
[Cp] País de publicação:France
[La] Idioma:eng
[Ab] Resumo:The French Health Products Agency concluded that etilefrine and heptaminol have an unfavourable harm-benefit balance, and also placed restrictions on the use of midodrine.
[Mh] Termos MeSH primário: Etilefrina/efeitos adversos
Heptaminol/efeitos adversos
Hipotensão/tratamento farmacológico
[Mh] Termos MeSH secundário: Seres Humanos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
3DQS188SY5 (Heptaminol); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1508
[Cu] Atualização por classe:150804
[Lr] Data última revisão:
150804
[Sb] Subgrupo de revista:T
[Da] Data de entrada para processamento:150805
[St] Status:MEDLINE


  3 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:26001324
[Au] Autor:Kremer JJ; Bills AJ; Hanke NJ; Chen H; Meier WA; Osinski MA; Foley CM
[Ad] Endereço:Covance Laboratories Inc., 3301 Kinsman Boulevard, Madison, WI 53704-2523, USA. Electronic address: john.kremer@covance.com.
[Ti] Título:Evaluation of cardiovascular changes in dogs administered three positive controls using jacketed external telemetry-blood pressure (JET-BP).
[So] Source:J Pharmacol Toxicol Methods;75:27-37, 2015 Sep-Oct.
[Is] ISSN:1873-488X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: Nonclinical safety studies are increasingly incorporating cardiac safety endpoints to discover potential cardiovascular liabilities. This trend for more thorough cardiovascular nonclinical safety evaluation is prudent given the high attrition rate of potential therapeutics due to unexpected cardiovascular liabilities discovered in late-stage clinical trials or post-market approval. In particular, the causal relationship of blood pressure changes that lead to risk of major adverse cardiac events suggests hemodynamic changes should be critically evaluated in preclinical studies of novel therapeutics. METHODS: Jacketed external telemetry with an implanted miniature blood pressure transmitter (JET-BP) was used to characterize the tolerability, functionality, and sensitivity of this study design in dogs. Thirty-six male or female beagles (n=6 dogs/sex/group) were administered vehicle control (reverse osmosis water) or etilefrine (1, 10mg/kg), sotalol (3, 30mg/kg), and hydralazine (1, 10mg/kg) on separate days. Telemetry data were evaluated for positive control article-related changes and retrospective power analysis was also completed. Animals were evaluated for instrumentation-related changes in clinical and anatomic pathology endpoints. RESULTS: All three positive controls elicited the expected pharmacologic responses that were statistically different at high and low doses. Retrospective power analysis confirmed this study design was able to statistically differentiate minor (approximately 5 to 15%) changes in electrocardiography and blood pressure values. This study also demonstrated the potential advantages of combining cardiovascular data across sex when the test article exposure and pharmacodynamics were consistent. Data collection using miniature telemetry blood pressure transmitters did not result in anatomic or clinical pathology findings that would prevent their use in general toxicology studies. DISCUSSION: This characterization study indicates that JET-BP in dogs offers a scientifically-robust method to evaluate novel therapeutics for potential cardiovascular liabilities.
[Mh] Termos MeSH primário: Pressão Sanguínea/efeitos dos fármacos
Cardiotoxicidade/diagnóstico
Avaliação Pré-Clínica de Medicamentos/métodos
Telemetria/métodos
[Mh] Termos MeSH secundário: Animais
Cães
Relação Dose-Resposta a Droga
Eletrocardiografia/métodos
Etilefrina/administração & dosagem
Etilefrina/farmacologia
Feminino
Hidralazina/administração & dosagem
Hidralazina/farmacologia
Masculino
Projetos de Pesquisa
Sotalol/administração & dosagem
Sotalol/farmacologia
[Pt] Tipo de publicação:JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
26NAK24LS8 (Hydralazine); A6D97U294I (Sotalol); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1607
[Cu] Atualização por classe:150928
[Lr] Data última revisão:
150928
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150524
[St] Status:MEDLINE


  4 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25808696
[Au] Autor:Hara R; Nagai A; Fujii T; Fukumoto K; Ohira S; Jo Y; Yokoyama T; Miyaji Y
[Ad] Endereço:Department of Urology, Kawasaki Medical School, Kurashiki, Okayama, Japan.
[Ti] Título:Practical application of color Doppler ultrasonography in patients with ejaculatory dysfunction.
[So] Source:Int J Urol;22(6):609-11, 2015 Jun.
[Is] ISSN:1442-2042
[Cp] País de publicação:Australia
[La] Idioma:eng
[Ab] Resumo:We describe two cases in which dynamic analysis of ejaculation using color Doppler ultrasonography was useful in diagnosis of ejaculatory dysfunction and planning of therapy. The first patient was a 32-year-old man with a diagnosis of retrograde ejaculation. A bladder neck collagen injection was carried out, as the main cause was thought to be the bladder neck remaining open during ejaculation. The patient had antegrade ejaculation 1 week later. The second patient was a 48-year-old man with a diagnosis of anorgasmia accompanied by decreased seminal emission and insufficient function of the rhythmic pelvic striated muscles. The patient was prescribed etilefrine hydrochloride 15 mg/day. The symptom improved 2 weeks after starting this drug. These cases suggest that the use of color Doppler ultrasonography during ejaculation can improve the understanding of ejaculatory dysfunction and therapy for this condition.
[Mh] Termos MeSH primário: Ejaculação
Disfunções Sexuais Fisiológicas/diagnóstico por imagem
Ultrassonografia Doppler em Cores
[Mh] Termos MeSH secundário: Adulto
Colágeno/administração & dosagem
Etilefrina/administração & dosagem
Seres Humanos
Masculino
Meia-Idade
Orgasmo
Disfunções Sexuais Fisiológicas/fisiopatologia
Disfunções Sexuais Fisiológicas/terapia
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
9007-34-5 (Collagen); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1603
[Cu] Atualização por classe:161125
[Lr] Data última revisão:
161125
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:150327
[St] Status:MEDLINE
[do] DOI:10.1111/iju.12754


  5 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25219539
[Au] Autor:Niehoff MO; Niggemann B; Sternberg J; Jenkins A; Holbrook M
[Ad] Endereço:Covance Laboratories GmbH, Kesselfeld 29, 48163 Muenster, Germany. Electronic address: marc.niehoff@covance.com.
[Ti] Título:Measurement of hyper- and hypotension during repeated dose toxicity studies in either freely moving or physically restrained cynomolgus monkeys.
[So] Source:J Pharmacol Toxicol Methods;70(3):268-75, 2014 Nov-Dec.
[Is] ISSN:1873-488X
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:INTRODUCTION: The measurement of cardiovascular endpoints in standard toxicology studies remains a challenge as the routinely used non-invasive methods require physical restraint, causing an increase of sympathetic neural activity, leading to excitement and potentially hypertension in the experimental animals. In this study, a miniature telemetry blood pressure transmitter was used to evaluate if the acute hyper- and hypotension could be detected in free moving cynomolgus monkeys as well as physically restrained animals using positive control drugs. Furthermore, as a comparator, routine high definition oscillometry (HDO) was performed in restrained animals. METHODS: Hemodynamic parameters were monitored continuously from conscious, freely moving animals following oral administration of vehicle (water) or 1 and 10mg/kg of etilefrine, and 1 and 4mg/kg of dihydralazine as positive control articles. A second dose session was performed to confirm the reproducibility of results and a third dose session combined with physical restraint procedures for blood collection and HDO measurements. RESULTS: There was a dose-dependent, statistically significant increase in the systolic blood pressure following oral doses of etilefrine at all 3 dose sessions. This effect was less apparent during session 3, probably due to the physical restraint applied for the blood sampling and HDO measurement. No differences in the blood pressure were measured using HDO. On all three dose sessions following oral doses of dihydralazine the expected statistically significant decrease in the diastolic pressure could be clearly measured even when the telemetric data recordings were combined with physical restraint. DISCUSSION: Due to the advantages of the minimally invasive telemetry technique compared to HDO and the possibility of prolonged measurement periods, it is an invaluable tool for blood pressure measurement in freely moving animals in toxicology studies.
[Mh] Termos MeSH primário: Monitorização Ambulatorial da Pressão Arterial/veterinária
Pressão Sanguínea/efeitos dos fármacos
Di-Hidralazina/toxicidade
Etilefrina/toxicidade
Macaca fascicularis/fisiologia
Restrição Física/veterinária
[Mh] Termos MeSH secundário: Administração Oral
Animais
Monitores de Pressão Arterial/veterinária
Di-Hidralazina/administração & dosagem
Relação Dose-Resposta a Droga
Etilefrina/administração & dosagem
Modelos Animais
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
PCU411F5L6 (Dihydralazine); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1509
[Cu] Atualização por classe:141209
[Lr] Data última revisão:
141209
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140916
[St] Status:MEDLINE


  6 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:25143252
[Au] Autor:Kong N; Yi R; Zhao S; Sandhu J; Lam G; Loganathan D; Morrissey B
[Ad] Endereço:Maxxam Analytics, Burnaby, BC, Canada.
[Ti] Título:Development and validation of a hydrophilic interaction liquid chromatography with tandem mass spectrometry method for the simultaneous detection and quantification of etilefrine and oxilofrine in equine blood plasma and urine.
[So] Source:J Sep Sci;37(21):3015-23, 2014 Nov.
[Is] ISSN:1615-9314
[Cp] País de publicação:Germany
[La] Idioma:eng
[Ab] Resumo:A sensitive hydrophilic interaction liquid chromatography coupled with tandem mass spectrometry method was developed and validated for the simultaneous detection and quantification of etilefrine and oxilofrine in equine blood plasma and urine. The method is highly sensitive and specific with good precision and accuracy. In plasma the limit of detection and limit of quantification are 0.03 and 0.1 ng/mL, respectively, for both analytes. In urine the limit of detection and limit of quantification are 0.3 and 1 ng/mL, respectively, for both analytes. The suitability of the method for doping control analysis in equine species is demonstrated by analyzing postadministration samples collected after a single intravenous administration of 50 mg etilefrine to a standardbred mare. Etilefrine was detected up to 120 h in urine and up to 48 h in plasma. Etilefrine is highly conjugated in equine urine whereas it exists in the free form in equine plasma. Therefore, enzyme hydrolysis prior to sample preparation is recommended for the detection and quantification of etilefrine and oxilofrine in equine urine.
[Mh] Termos MeSH primário: Cardiotônicos/sangue
Cardiotônicos/urina
Cromatografia Líquida de Alta Pressão/métodos
Efedrina/análogos & derivados
Etilefrina/sangue
Etilefrina/urina
Espectrometria de Massas em Tandem/métodos
[Mh] Termos MeSH secundário: Animais
Cromatografia Líquida de Alta Pressão/instrumentação
Doping nos Esportes
Efedrina/sangue
Efedrina/urina
Cavalos
Espectrometria de Massas em Tandem/veterinária
[Pt] Tipo de publicação:EVALUATION STUDIES; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Cardiotonic Agents); F49638UBDR (oxilofrine); GN83C131XS (Ephedrine); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1506
[Cu] Atualização por classe:141023
[Lr] Data última revisão:
141023
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:140822
[St] Status:MEDLINE
[do] DOI:10.1002/jssc.201400662


  7 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:22205274
[Au] Autor:Kokki M; Ali M; Turunen M; Kokki H
[Ti] Título:Suspected unexpected adverse effect of sugammadex: hypotension.
[So] Source:Eur J Clin Pharmacol;68(5):899-900, 2012 May.
[Is] ISSN:1432-1041
[Cp] País de publicação:Germany
[La] Idioma:eng
[Mh] Termos MeSH primário: Anestésicos Inalatórios/antagonistas & inibidores
Hipotensão/induzido quimicamente
Bloqueadores Neuromusculares/antagonistas & inibidores
gama-Ciclodextrinas/efeitos adversos
[Mh] Termos MeSH secundário: Adulto
Quimioterapia Combinada
Etilefrina/uso terapêutico
Feminino
Seres Humanos
Hipotensão/tratamento farmacológico
Hipotensão/fisiopatologia
Fenilefrina/uso terapêutico
Índice de Gravidade de Doença
Resultado do Tratamento
Vasoconstritores/uso terapêutico
[Pt] Tipo de publicação:CASE REPORTS; LETTER
[Nm] Nome de substância:
0 (Anesthetics, Inhalation); 0 (Neuromuscular Blocking Agents); 0 (Vasoconstrictor Agents); 0 (gamma-Cyclodextrins); 1WS297W6MV (Phenylephrine); 361LPM2T56 (Sugammadex); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1208
[Cu] Atualização por classe:170920
[Lr] Data última revisão:
170920
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:111230
[St] Status:MEDLINE
[do] DOI:10.1007/s00228-011-1196-z


  8 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:21370727
[Au] Autor:Bobadilla-González P; Pérez-Rangel I; García-Menaya JM; Sánchez-Vega S; Cordobés-Durán C; Zambonino-Carreiras MA
[Ad] Endereço:Department of Allergology and Clinical Immunology, Infanta Cristina University Hospital, Badajoz, Spain. pbg01ba@saludalia.com
[Ti] Título:Type IV reaction due to phenylephrine administered nasally with cross-reactivity with ethylephrine.
[So] Source:J Investig Allergol Clin Immunol;21(1):69-72, 2011.
[Is] ISSN:1018-9068
[Cp] País de publicação:Spain
[La] Idioma:eng
[Ab] Resumo:Type IV hypersensitivity eye reactions have been described after the administration of the sympathomimetic agent phenylephrine. We report the case of an atopic woman who developed nasal congestion and discharge, dysphagia, and dyspnea 1 hour after the administration of Stopcold pills and Disneumon Pernasal nasal spray for otitis. The same symptoms reappeared after the accidental administration of Rinobanedif ointment in the nasal mucosa. Skin patch tests were performed with a standard True Test panel, preservatives, Disneumon Pernasal, pseudoephedrine, eyedrops (tropicamide, cyclopentolate, and phenylephrine), and other sympathomimetic agents. The patient also underwent oral, ocular, and nasal controlled challenges with the same drugs. Finally, patch tests were performed in 11 controls with phenylephrine and ethylephrine. Our patient had a positive outcome in patch testing with nickel sulphate, fragrance mix, phenylephrine, and ethylephrine. To our knowledge, this is the first report of a type IV reaction to nasally administered phenylephrine with cross-reactivity with ethylephrine detected by patch testing.
[Mh] Termos MeSH primário: Hipersensibilidade a Drogas/etiologia
Hipersensibilidade Tardia/etiologia
Fenilefrina/efeitos adversos
Simpatomiméticos/efeitos adversos
[Mh] Termos MeSH secundário: Administração Intranasal
Reações Cruzadas
Diagnóstico Diferencial
Hipersensibilidade a Drogas/diagnóstico
Etilefrina/administração & dosagem
Etilefrina/efeitos adversos
Etilefrina/uso terapêutico
Feminino
Seres Humanos
Hipersensibilidade Tardia/diagnóstico
Meia-Idade
Testes do Emplastro
Fenilefrina/administração & dosagem
Fenilefrina/uso terapêutico
Simpatomiméticos/administração & dosagem
Simpatomiméticos/uso terapêutico
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Sympathomimetics); 1WS297W6MV (Phenylephrine); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1103
[Cu] Atualização por classe:131121
[Lr] Data última revisão:
131121
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:110305
[St] Status:MEDLINE


  9 / 163 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:21127308
[Au] Autor:Olujohungbe AB; Adeyoju A; Yardumian A; Akinyanju O; Morris J; Westerdale N; Akenova Y; Kehinde MO; Anie K; Howard J; Brooks A; Davis VA; Khoriatry AI
[Ad] Endereço:University Hospital Aintree, National Health Service Foundation Trust, Liverpool, United Kingdom. ade.olujohungbe@cancercare.mb.ca
[Ti] Título:A prospective diary study of stuttering priapism in adolescents and young men with sickle cell anemia: report of an international randomized control trial--the priapism in sickle cell study.
[So] Source:J Androl;32(4):375-82, 2011 Jul-Aug.
[Is] ISSN:1939-4640
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:Priapism is defined as a prolonged, persistent, and purposeless penile erection. It is a common (35%) but frequently understated complication in young men and adults with sickle cell disease. We had previously demonstrated an association between stuttering attacks (<4 hours) and an acute catastrophic event with its consequent problems of erectile dysfunction and impotence. We describe a randomized, placebo-controlled, clinical study looking at medical prophylaxis with 2 oral α-adrenergic agonists, etilefrine and ephedrine, in preventing stuttering attacks of priapism. One hundred thirty-one patients were registered into a 2-phase (observational and intervention phase) study, and 86 patients (66%) completed Phase A diary charts. Forty-six patients (59%) completed a 6-month treatment phase (Phase B), and the remaining patients were lost to follow-up despite persistent efforts to contact them. Various reasons are postulated for the high attrition rates. The drugs were well tolerated, and no serious adverse events were reported. There was no significant difference among the 4 treatment groups in the weekly total number of attacks in Phase B (analysis of covariance P = .99) nor among the average pain score per attack after adjusting for attack rates and pain scores in Phase A (analysis of covariance P = .33). None of the patients who completed the study required penile aspiration at study sites while on medical prophylaxis. Young men with sickle cell disease are not comfortable engaging with health care providers about issues relating to their sexual health. The full impact of an improved awareness campaign and early presentation to hospital merits further standardized study. Priapism still contributes seriously to the comorbidity experienced by this previously inaccessible group of patients and medical prophylaxis with oral α-adrenergic agonists is feasible. Future international collaborative efforts using some of the lessons learnt in this study should be undertaken.
[Mh] Termos MeSH primário: Agonistas de Receptores Adrenérgicos alfa 2/uso terapêutico
Anemia Falciforme/complicações
Priapismo/tratamento farmacológico
Gagueira/complicações
[Mh] Termos MeSH secundário: Adolescente
Adulto
Efedrina/uso terapêutico
Disfunção Erétil/etiologia
Etilefrina/efeitos adversos
Etilefrina/uso terapêutico
Seres Humanos
Perda de Seguimento
Masculino
Registros Médicos
Meia-Idade
Cooperação do Paciente
Priapismo/etiologia
Estudos Prospectivos
Gagueira/tratamento farmacológico
[Pt] Tipo de publicação:JOURNAL ARTICLE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL
[Nm] Nome de substância:
0 (Adrenergic alpha-2 Receptor Agonists); GN83C131XS (Ephedrine); ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1109
[Cu] Atualização por classe:160204
[Lr] Data última revisão:
160204
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:101204
[St] Status:MEDLINE
[do] DOI:10.2164/jandrol.110.010934


  10 / 163 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
[PMID]:20302181
[Au] Autor:Nuhn P; Stief CG
[Ad] Endereço:Urologische Klinik und Poliklinik, Ludwig-Maximilians-Universität München, Marchioninistrasse 15, D-81337 München. philipp.nuhn@med.uni-muenchen.de
[Ti] Título:[Emergency checklist: priapism].
[Ti] Título:Priapismus..
[So] Source:MMW Fortschr Med;152(6):41, 2010 Feb 11.
[Is] ISSN:1438-3276
[Cp] País de publicação:Germany
[La] Idioma:ger
[Mh] Termos MeSH primário: Priapismo
[Mh] Termos MeSH secundário: Diagnóstico Diferencial
Emergências
Etilefrina/administração & dosagem
Etilefrina/uso terapêutico
Seres Humanos
Masculino
Meia-Idade
Priapismo/classificação
Priapismo/diagnóstico
Priapismo/diagnóstico por imagem
Priapismo/tratamento farmacológico
Priapismo/cirurgia
Priapismo/terapia
Punções
Ultrassonografia Doppler em Cores
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
ZB6F8MY53V (Etilefrine)
[Em] Mês de entrada:1005
[Cu] Atualização por classe:161125
[Lr] Data última revisão:
161125
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:100323
[St] Status:MEDLINE



página 1 de 17 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde